Prospective Study of Efficacy and Safety of Lansoprazole in Zollinger-Ellison Syndrome

Lansoprazole, a new substituted benzimidazole H(+),K(+)-ATPase inhibitor, profoundly inhibits gastric acid secretion and has potential use in the management of diseases such as Zollinger-Ellison syndrome (ZES). In the present study we evaluated the efficacy and safety of lansoprazole in controlling...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Dig Dis Sci
Hlavní autoři: METZ, DAVID C., PISEGNA, JOSEPH R., RINGHAM, GARY L., FEIGENBAUM, KATHRYN, KOVIACK, PAMELA D., MATON, PAUL N., GARDNER, JERRY D., JENSEN, ROBERT T.
Médium: Artigo
Jazyk:Inglês
Vydáno: 1993
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721849/
https://ncbi.nlm.nih.gov/pubmed/8425437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/bf01307541
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky